Subscribe To
CRMD / Why Is Cormedix (CRMD) Stock Down 23% Today?
CRMD News
By The Motley Fool
June 29, 2023
Why Shares of CorMedix Are Slumping Thursday
CorMedix's lead therapy is DefenCath. The company is awaiting word from the FDA on the therapy's approval. more_horizontal
By InvestorPlace
June 29, 2023
Why Is Cormedix (CRMD) Stock Down 23% Today?
Cormedix (NASDAQ: CRMD ) stock is falling hard on Thursday after the company priced a public offering of its shares. That public offering has the comp more_horizontal
By Seeking Alpha
May 15, 2023
CorMedix Inc. (CRMD) Q1 2023 Earnings Call Transcript
CorMedix Inc. (NASDAQ:CRMD ) Q1 2023 Earnings Call May 15, 2023 4:30 PM ET Company Participants Joe Todisco - Chief Executive Officer Matt David - Exe more_horizontal
By Zacks Investment Research
April 27, 2023
Here's Why CorMedix (CRMD) Looks Ripe for Bottom Fishing
After losing some value lately, a hammer chart pattern has been formed for CorMedix (CRMD), indicating that the stock has found support. This, combine more_horizontal
By Seeking Alpha
November 10, 2022
CorMedix (CRMD) Q3 2022 Earnings Call Transcript
CorMedix Inc. (NASDAQ:CRMD ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Joe Todisco - Chief Executive Officer more_horizontal
By The Motley Fool
August 9, 2022
Why CorMedix Stock Was Plummeting on Tuesday
Bad news on the regulatory front leads investors to bail en masse from the company. more_horizontal
By Seeking Alpha
May 12, 2022
CorMedix Inc. (CRMD) CEO Joe Todisco on Q1 2022 Results - Earnings Call Transcript
CorMedix Inc. (NASDAQ:CRMD ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Daniel Ferry - Investor Relations Joe Todis more_horizontal
By Seeking Alpha
March 29, 2022
CorMedix Inc. (CRMD) CEO Matt David on Q4 2021 Results - Earnings Call Transcript
CorMedix Inc. (CRMD) CEO Matt David on Q4 2021 Results - Earnings Call Transcript more_horizontal